Oramed Pharmaceuticals
ORMP
#8931
Rank
$95.53 M
Marketcap
$2.37
Share price
-4.82%
Change (1 day)
-0.42%
Change (1 year)

Earnings for Oramed Pharmaceuticals (ORMP)

Earnings in 2024 (TTM): $24.64 Million USD

According to Oramed Pharmaceuticals's latest financial reports the company's current earnings are N/A. In 2023 the company made an earning of $7.12 Million USD, an increase over its 2022 earnings that were of -$36.63 Million USD. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Oramed Pharmaceuticals from 2006 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) $24.64 M245.87%
2023 $7.12 M-119.45%
2022 -$36.63 Million39.17%
2021 -$26.32 Million73.93%
2020 -$15.14 Million18.53%
2019 -$12.77 Million-16.62%
2018 -$15.32 Million38.32%
2017 -$11.07 Million12.51%
2016 -$9.84 Million25.01%
2015 -$7.87 Million18.18%
2014 -$6.66 Million39.72%
2013 -$4.77 Million46.4%
2012 -$3.26 Million128.32%
2011 -$1.43 Million-51.47%
2010 -$2.94 Million35.21%
2009 -$2.18 Million
2007 -$3.42 Million607.04%
2006 -$0.49 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-$0.5 Billion-2,113.66%๐Ÿ‡บ๐Ÿ‡ธ USA
$17.84 B 72,308.80%๐Ÿ‡ฉ๐Ÿ‡ฐ Denmark
$7.40 B 29,960.63%๐Ÿ‡ซ๐Ÿ‡ท France
$15.12 M-38.63%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
-$0.22 Billion-978.11%๐Ÿ‡บ๐Ÿ‡ธ USA